Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

High Efficiency Coupling Between Beta-adrenergic Receptors and Cardiac Contractility: Direct Evidence for "Spare" Beta-adrenergic Receptors

J. CRAIG VENTER
Molecular Pharmacology September 1979, 16 (2) 429-440;
J. CRAIG VENTER
Department of Pharmacology and Therapeutics, School of Medicine, State University of New York at Buffalo, 127 Farber Hall, Buffalo, New York 14214
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The relationship between the concentration of β-adrenergic receptors and the activation of heart muscle by isoproterenol was investigated using the irreversible β-adrenergic receptor antagonist NHNP-NBE. The interaction of NHNP-NBE with β-receptors was characterized in isolated membranes, whole cells and intact cardiac muscle, using [125I]-iodohydroxybenzylpindolol (IHYP). Formation of the NHNP-NBE-β-receptor complex was found to be irreversible and dependent on incubation time, temperature and ligand concentration. Occupation of β-receptors by adrenergic ligands prior to NHNP-NBE exposure protected the receptors from inactivation. These data are consistent with a covalent modification of β-receptors by NHNP-NBE at a site in or near the adrenergic ligand binding site. Incubation of NHNP-NBE with intact cardiac muscle produced a dose dependent β-receptor inactivation that survived tissue homogenization and membrane isolation. NHNP-NBE dramatically affects the concentrations at which isoproterenol produces positive inotropic responses in cat papillary muscles. The ED50 for isoproterenol under control conditions averaged 9.8 nM. The ED50 of isoproterenol increased to 22; 70; 500 and 5623 nM subsequent to a 10 min treatment of the muscles with 0.1; 1.0; 10 and 100 µM NHNP-NBE respectively. The same maximum inotropic response was achieved with isoproterenol following each concentration of NHNP-NBE. Ten micromolar isoproterenol subsequent to 100 µM NHNP-NBE increased the papillary muscle concentration of cyclic AMP to the same extent as 10 µM isoproterenol alone. Although the maximum cyclic AMP response was essentially identical, the time course for cyclic AMP production was substantially slower following irreversible β-receptor blockade. The ED50 for isoproterenol induced increases in cyclic AMP concentrations was 15 nM in the absence of NHNP-NBE and 600 nM following 100 µM NHNP-NBE. In contrast to the cardiac data, NHNP-NBE stoichiometrically inhibited IHYP binding and isoproterenol induced cyclic AMP formation in cultured human lung (VA2) cells. These data indicate a high efficiency coupling between the isoproterenol-β-adrenergic receptor interaction, cyclic AMP formation and increased cardiac contractility, an efficiency not apparent with isoproterenol-induced cyclic AMP formation in cultured cells.

ACKNOWLEDGMENT The author is indebted to Ms. Rose Agro for excellent technical assistance and Dr. David Triggle for the synthesis of NHNP-NBE.

  • Copyright © 1979 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 16, Issue 2
1 Sep 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
High Efficiency Coupling Between Beta-adrenergic Receptors and Cardiac Contractility: Direct Evidence for "Spare" Beta-adrenergic Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

High Efficiency Coupling Between Beta-adrenergic Receptors and Cardiac Contractility: Direct Evidence for "Spare" Beta-adrenergic Receptors

J. CRAIG VENTER
Molecular Pharmacology September 1, 1979, 16 (2) 429-440;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

High Efficiency Coupling Between Beta-adrenergic Receptors and Cardiac Contractility: Direct Evidence for "Spare" Beta-adrenergic Receptors

J. CRAIG VENTER
Molecular Pharmacology September 1, 1979, 16 (2) 429-440;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics